NPPA fixed the retail price of the Glimepiride IP 0.5 mg + Voglibose IP 0.2mg + Metformin Hydrochloride IP 500mg

Dec 17, 2024 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on December 16, 2024, fixed the retail price of the Glimepiride IP 0.5 mg + Voglibose IP 0.2mg + Metformin Hydrochloride IP 500mg (as sustained release form).

The following has been stated:

The retail price for the Glimepiride IP 0.5 mg + Voglibose IP 0.2mg + Metformin Hydrochloride IP 500mg (as sustained release form) for M/s Windlass Biotech Ltd. (Manufacturer) & M/s Mankind Pharma ltd (Marketer) will be Rs. 9.12/-.

[Notification No. 19(4310)/2024/DP/NPPA/Div.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT